Marc Klepner advises clients on all aspects of complex, multijurisdictional transactions.

Marc draws on extensive experience across deal structures and deep knowledge of each client’s internal processes to represent private equity funds and strategic investors in:

  • Mergers, acquisitions, and dispositions
  • Carve-outs
  • Joint ventures
  • General corporate matters

He advises clients across a broad array of industries, including energy and infrastructure, healthcare, technology, manufacturing, and industrials. 

A recognized leader at the firm, Marc serves on Latham’s Inclusion, Opportunity & Community (IOC) Committee.

Marc's experience includes representing:

  • One Rock Capital Partners in its:
    • Acquisition and sale of ArchKey Solutions, a national electrical contractor
    • Acquisition of EnviroServe, an environmental remediation, waste management, and emergency response services provider
    • Carve-out acquisition of Therm-O-Disc, a leading designer and manufacturer of sensors
    • Carve-out acquisition of Kensing, a specialty chemicals manufacturer
    • Strategic investment in BrightView, a commercial landscaping provider
    • Sale of Orion Food Systems, a food products manufacturer and distributor
    • Sale of Monarch Landscape Companies, a commercial landscaping provider
    • Sale of North Pacific Paper Company, a producer of environmentally sustainable lightweight recycled packaging papers
  • Astorg Partners in:
    • Its US$1.075 billion acquisition of Thermo Fisher Scientific’s global microbiology business
    • The US$2.5 billion sale of its portfolio company Anaqua, an IP management software business
    • Its US$3.8 billion investment in Clario, a clinical trials solutions company
    • Portfolio company IQ-EQ’s acquisition of South Watch, a hedge fund administration provider
    • Portfolio company Anaqua’s acquisition of Actio IP, a tech-enabled IP services company
    • Portfolio company CordenPharma’s acquisition of AmbioPharm, a peptide API contract development and manufacturing organization
  • Clario (an Astorg Partners portfolio company) in its:
    • US$9.5 billion sale to Thermo Fisher Scientific inclusive of performance based earn out payments
    • Carve-out acquisition of WCG’s eCOA business 
    • Acquisition of ArtiQ, a Belgium-based medical software company focused on the diagnosis and treatment for patients with lung diseases
    • Acquisition of Inofab, a Turkey-based digital respiratory health platform for chronic conditions
    • Sale of its Software Solutions business, an end-to-end solution to support the clinical trial life cycle, to Sitero
    • Sale of its Drug Safety Solutions business to Stanley Capital Partners
  • Astorg Partners and Nordic Capital in their:
    • Carve-out sale of Clario’s bio-pharmaceutical consultancy business
    • Carve-out sale of Clario’s software solutions business
  • Ares in its:
    • Joint venture with Savion Equity to form Tango Holdings to support solar energy development
    • Sale of 49.9% of Phoenix Wind Repower
    • Sale of 51% of Aviator Wind
  • Ørsted in its:
    • Sale of a 50% ownership stake in a portfolio consisting of three onshore wind farms and one solar farm in the US
    • Sale of an 80% stake in a renewable portfolio comprised of the Ford Ridge, Helena, Western Trail, and Sunflower wind projectsAntin Infrastructure Partners and Brookfield Asset Management in its majority investment in Origis Energy, a leading renewable energy provider
  • Goldman Sachs Asset Management in its strategic partnership with Excel Sports Management

Bar Qualification

  • New York

Education

  • JD, Fordham University School of Law, 2017
    cum laude
  • BA in Government & Politics, University of Maryland, 2014

Languages Spoken

  • English